Table 4.
Variable | Baseline | 1 month | 3 months | 6 months | 12 months |
---|---|---|---|---|---|
Uroflowmetric parameters | |||||
Vioded Vol.(mL) | |||||
Naftopidil (n=70) | 260 (129) |
153** (95) | 141** (72) | 155** (72) | 185** (128) |
Silodosin (n=71) | 209 (111) | 151** (89) | 128** (81) | 144** (76) | 172** (100) |
Total (n=141) | 236 (123) | 152** (92) | 135** (77) | 150** (74) | 178** (115) |
Qmax (mL/s) | |||||
Naftopidil (n=70) | 13.2 (6.0) | 9.7** (4.4) | 8.8** (3.8) | 8.9** (3.3) | 11.4** (5.4) |
Silodosin (n=71) | 12.1 (5.2) | 9.4** (4.5) | 8.7** (4.4) | 9.5** (4.6) | 11.0** (5.4) |
Total (n=141) | 12.6 (5.7) | 9.6** (4.4) | 8.7** (4.1) | 9.2** (4.0) | 11.2** (5.4) |
PVR (mL) | |||||
Naftopidil (n=70) | 19 (38) | 36** (45) | 32** (39) | 34** (38) | 25 (36) |
Silodosin (n=71) | 23 (27) | 38** (36) | 52** (71) | 37** (34) | 35* (45) |
Total (n=141) | 21 (34) | 37** (41) | 42** (58) | 35** (36) | 30* (41) |
*p < 0.05, **p < 0.01.